AT1 FY21 - General Discussion + FA, page-315

Hi All,

new to this stock but looking to get exposure to health tech in my portfolio and the market cap / stable equipment manufacturer as opposed to drug producer (and hence more predictable earnings) has interested me.

Have spent the last week or so going through the thread and a lot of great analysis by all. Its great theres a core group of really analytical folks within the thread.

Just a quick query and apologies if already covered - why did the auditors (KPMG) resign in July and new auditors (BDO) pick it up? did anyone find this strange? or is it simply due to end of contract / or that BDO assisted on the IPO and made more sense?

Also, do you all think covid has been a blessing for this stock and accelerated its growth / exposure or on flip side think that once (or if) a vaccine is found the stock is likely to regress as they have pivoted into this potential short term product development to capitalise and may have oversupply of potential obsolete / less demanded testing kits to the detriment of focussing on their strength / core product in HIV testing.